COVID-19 Impact on Acromegaly Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Acromegaly Industry
1.7 COVID-19 Impact: Acromegaly Market Trends
2 Global Acromegaly Quarterly Market Size Analysis
2.1 Acromegaly Business Impact Assessment - COVID-19
2.1.1 Global Acromegaly Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Acromegaly Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Acromegaly Quarterly Market Size, 2019 VS 2020
3.2 By Players, Acromegaly Headquarters and Area Served
3.3 Date of Key Players Enter into Acromegaly Market
3.4 Key Players Acromegaly Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Acromegaly Segments, By Type
4.1 Introduction
1.4.1 Somatostatin Analogues
1.4.2 Dopamine Agonists
1.4.3 Growth Hormone Receptor Antagonists
1.4.4 Other
4.2 By Type, Global Acromegaly Market Size, 2019-2021
5 Impact of Covid-19 on Acromegaly Segments, By Application
5.1 Overview
5.5.1 Hospitals
5.5.2 Clinics
5.2 By Application, Global Acromegaly Market Size, 2019-2021
5.2.1 By Application, Global Acromegaly Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Business Overview
7.1.2 Novartis Acromegaly Quarterly Revenue, 2020
7.1.3 Novartis Acromegaly Product Introduction
7.1.4 Novartis Response to COVID-19 and Related Developments
7.2 Aegis Therapeutics
7.2.1 Aegis Therapeutics Business Overview
7.2.2 Aegis Therapeutics Acromegaly Quarterly Revenue, 2020
7.2.3 Aegis Therapeutics Acromegaly Product Introduction
7.2.4 Aegis Therapeutics Response to COVID-19 and Related Developments
7.3 Chiasma
7.3.1 Chiasma Business Overview
7.3.2 Chiasma Acromegaly Quarterly Revenue, 2020
7.3.3 Chiasma Acromegaly Product Introduction
7.3.4 Chiasma Response to COVID-19 and Related Developments
7.4 Crinetics Pharmaceuticals
7.4.1 Crinetics Pharmaceuticals Business Overview
7.4.2 Crinetics Pharmaceuticals Acromegaly Quarterly Revenue, 2020
7.4.3 Crinetics Pharmaceuticals Acromegaly Product Introduction
7.4.4 Crinetics Pharmaceuticals Response to COVID-19 and Related Developments
7.5 Daewoong Pharmaceutical
7.5.1 Daewoong Pharmaceutical Business Overview
7.5.2 Daewoong Pharmaceutical Acromegaly Quarterly Revenue, 2020
7.5.3 Daewoong Pharmaceutical Acromegaly Product Introduction
7.5.4 Daewoong Pharmaceutical Response to COVID-19 and Related Developments
7.6 Peptron
7.6.1 Peptron Business Overview
7.6.2 Peptron Acromegaly Quarterly Revenue, 2020
7.6.3 Peptron Acromegaly Product Introduction
7.6.4 Peptron Response to COVID-19 and Related Developments
7.7 Silence Therapeutics
7.7.1 Silence Therapeutics Business Overview
7.7.2 Silence Therapeutics Acromegaly Quarterly Revenue, 2020
7.7.3 Silence Therapeutics Acromegaly Product Introduction
7.7.4 Silence Therapeutics Response to COVID-19 and Related Developments
7.8 Strongbridge Biopharma
7.8.1 Strongbridge Biopharma Business Overview
7.8.2 Strongbridge Biopharma Acromegaly Quarterly Revenue, 2020
7.8.3 Strongbridge Biopharma Acromegaly Product Introduction
7.8.4 Strongbridge Biopharma Response to COVID-19 and Related Developments
7.9 Amryt Pharma
7.9.1 Amryt Pharma Business Overview
7.9.2 Amryt Pharma Acromegaly Quarterly Revenue, 2020
7.9.3 Amryt Pharma Acromegaly Product Introduction
7.9.4 Amryt Pharma Response to COVID-19 and Related Developments
7.10 Foresee Pharmaceuticals
7.10.1 Foresee Pharmaceuticals Business Overview
7.10.2 Foresee Pharmaceuticals Acromegaly Quarterly Revenue, 2020
7.10.3 Foresee Pharmaceuticals Acromegaly Product Introduction
7.10.4 Foresee Pharmaceuticals Response to COVID-19 and Related Developments
7.11 Glide Pharmaceutical
7.11.1 Glide Pharmaceutical Business Overview
7.11.2 Glide Pharmaceutical Acromegaly Quarterly Revenue, 2020
7.11.3 Glide Pharmaceutical Acromegaly Product Introduction
7.11.4 Glide Pharmaceutical Response to COVID-19 and Related Developments
7.12 Ionis Pharmaceuticals
7.12.1 Ionis Pharmaceuticals Business Overview
7.12.2 Ionis Pharmaceuticals Acromegaly Quarterly Revenue, 2020
7.12.3 Ionis Pharmaceuticals Acromegaly Product Introduction
7.12.4 Ionis Pharmaceuticals Response to COVID-19 and Related Developments
7.13 Ipsen
7.13.1 Ipsen Business Overview
7.13.2 Ipsen Acromegaly Quarterly Revenue, 2020
7.13.3 Ipsen Acromegaly Product Introduction
7.13.4 Ipsen Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Acromegaly Assessment
Table 9. COVID-19 Impact: Acromegaly Market Trends
Table 10. COVID-19 Impact Global Acromegaly Market Size
Table 11. Global Acromegaly Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Acromegaly Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Acromegaly Market Growth Drivers
Table 14. Global Acromegaly Market Restraints
Table 15. Global Acromegaly Market Opportunities
Table 16. Global Acromegaly Market Challenges
Table 17. By Players, Acromegaly Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Acromegaly Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Acromegaly Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Acromegaly Market
Table 21. Key Players Acromegaly Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Acromegaly Market Size 2019-2021, (US$ Million)
Table 24. Global Acromegaly Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Acromegaly Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Acromegaly Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Acromegaly Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Acromegaly Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Acromegaly Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Acromegaly Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Acromegaly Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Acromegaly Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Acromegaly Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Acromegaly Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Acromegaly Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Acromegaly Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Acromegaly Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Acromegaly Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Acromegaly Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Acromegaly Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Acromegaly Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Acromegaly Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Acromegaly Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Acromegaly Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Acromegaly Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Acromegaly Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Acromegaly Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Acromegaly Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Acromegaly Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Acromegaly Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Acromegaly Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Acromegaly Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Acromegaly Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Acromegaly Market Size, 2019-2021 (US$ Million)
Table 57. Novartis Business Overview
Table 58. Novartis Acromegaly Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Novartis Acromegaly Product
Table 60. Novartis Response to COVID-19 and Related Developments
Table 61. Aegis Therapeutics Business Overview
Table 62. Aegis Therapeutics Acromegaly Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Aegis Therapeutics Acromegaly Product
Table 64. Aegis Therapeutics Response to COVID-19 and Related Developments
Table 65. Chiasma Business Overview
Table 66. Chiasma Acromegaly Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Chiasma Acromegaly Product
Table 68. Chiasma Response to COVID-19 and Related Developments
Table 69. Crinetics Pharmaceuticals Business Overview
Table 70. Crinetics Pharmaceuticals Acromegaly Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Crinetics Pharmaceuticals Acromegaly Product
Table 72. Crinetics Pharmaceuticals Response to COVID-19 and Related Developments
Table 73. Daewoong Pharmaceutical Business Overview
Table 74. Daewoong Pharmaceutical Acromegaly Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Daewoong Pharmaceutical Acromegaly Product
Table 76. Daewoong Pharmaceutical Response to COVID-19 and Related Developments
Table 77. Peptron Business Overview
Table 78. Peptron Acromegaly Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Peptron Acromegaly Product
Table 80. Peptron Response to COVID-19 and Related Developments
Table 81. Silence Therapeutics Business Overview
Table 82. Silence Therapeutics Acromegaly Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Silence Therapeutics Acromegaly Product
Table 84. Silence Therapeutics Response to COVID-19 and Related Developments
Table 85. Strongbridge Biopharma Business Overview
Table 86. Strongbridge Biopharma Acromegaly Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Strongbridge Biopharma Acromegaly Product
Table 88. Strongbridge Biopharma Response to COVID-19 and Related Developments
Table 89. Amryt Pharma Business Overview
Table 90. Amryt Pharma Acromegaly Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Amryt Pharma Acromegaly Product
Table 92. Amryt Pharma Response to COVID-19 and Related Developments
Table 93. Foresee Pharmaceuticals Business Overview
Table 94. Foresee Pharmaceuticals Acromegaly Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Foresee Pharmaceuticals Acromegaly Product
Table 96. Foresee Pharmaceuticals Response to COVID-19 and Related Developments
Table 97. Glide Pharmaceutical Business Overview
Table 98. Glide Pharmaceutical Acromegaly Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Glide Pharmaceutical Acromegaly Product
Table 100. Glide Pharmaceutical Response to COVID-19 and Related Developments
Table 101. Ionis Pharmaceuticals Business Overview
Table 102. Ionis Pharmaceuticals Acromegaly Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Ionis Pharmaceuticals Acromegaly Product
Table 104. Ionis Pharmaceuticals Response to COVID-19 and Related Developments
Table 105. Ipsen Business Overview
Table 106. Ipsen Acromegaly Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Ipsen Acromegaly Product
Table 108. Ipsen Response to COVID-19 and Related Developments
List of FiguresFigure 1. Acromegaly Product Picture
Figure 2. Acromegaly Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Acromegaly Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Acromegaly Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Acromegaly Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Acromegaly Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Acromegaly Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Acromegaly Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Acromegaly Market Size Market Share, 2019-2021